Nerve, muscle or bone disease? Look before you leap

Area of Science:

• Neurology
• Endocrinology
• Metabolic Bone Disease

Background:

• Osteomalacia can present with severe muscle weakness, potentially misdiagnosed as primary neuromuscular disorders.
• Spinal muscular atrophy (SMA) is a progressive, degenerative neuromuscular condition.
• Distinguishing between treatable metabolic myopathies and fatal degenerative diseases is crucial for patient management.

Observation:

• A 32-year-old woman presented with severe muscle weakness.
• Initial diagnosis, based on clinical findings, electromyography, and muscle biopsy, was spinal muscular atrophy.
• Further investigation revealed osteomalacic myopathy secondary to primary hyperparathyroidism and vitamin D deficiency.

Findings:

• The patient's severe muscle weakness was attributed to osteomalacic myopathy, not spinal muscular atrophy.
• Primary hyperparathyroidism and vitamin D deficiency were identified as the underlying causes.
• This case highlights the importance of a comprehensive differential diagnosis.

Implications:

• Treatable conditions presenting as neuromuscular disorders must be excluded before diagnosing progressive, fatal diseases like spinal muscular atrophy.
• Early diagnosis and management of vitamin D deficiency and hyperparathyroidism can prevent irreversible neurological damage.
• This underscores the need for integrated diagnostic approaches in neurology and endocrinology.